AU2003252694A1 - External preparation - Google Patents

External preparation

Info

Publication number
AU2003252694A1
AU2003252694A1 AU2003252694A AU2003252694A AU2003252694A1 AU 2003252694 A1 AU2003252694 A1 AU 2003252694A1 AU 2003252694 A AU2003252694 A AU 2003252694A AU 2003252694 A AU2003252694 A AU 2003252694A AU 2003252694 A1 AU2003252694 A1 AU 2003252694A1
Authority
AU
Australia
Prior art keywords
external preparation
preparation
external
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003252694A
Inventor
Takayuki Ishii
Katsunori Morishita
Toshiaki Sato
Tomoaki Takigawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mikasa Seiyaku Co Ltd
Original Assignee
Mikasa Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikasa Seiyaku Co Ltd filed Critical Mikasa Seiyaku Co Ltd
Publication of AU2003252694A1 publication Critical patent/AU2003252694A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/719—Pullulans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/732—Pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2003252694A 2002-07-26 2003-07-25 External preparation Abandoned AU2003252694A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002-217580 2002-07-26
JP2002217580 2002-07-26
JP2002217581 2002-07-26
JP2002-217581 2002-07-26
PCT/JP2003/009446 WO2004011032A1 (en) 2002-07-26 2003-07-25 External preparation

Publications (1)

Publication Number Publication Date
AU2003252694A1 true AU2003252694A1 (en) 2004-02-16

Family

ID=31190301

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003252694A Abandoned AU2003252694A1 (en) 2002-07-26 2003-07-25 External preparation

Country Status (3)

Country Link
JP (1) JP4712380B2 (en)
AU (1) AU2003252694A1 (en)
WO (1) WO2004011032A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
EP1773414A1 (en) * 2004-07-08 2007-04-18 Alltracel Development Services Limited A delivery system for controlling the bleeding of skin wounds
EP1803464A4 (en) * 2004-09-17 2009-09-09 Cellgentech Inc External preparation for treating skin ulcer
CA2581287C (en) * 2004-09-17 2015-08-25 Durect Corporation Sustained local anesthetic composition containing bupivacaine and saib
US20090041859A1 (en) * 2005-04-08 2009-02-12 Mie University Wound Treatment Drugs for External Use
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
WO2007119486A1 (en) * 2006-03-22 2007-10-25 Cellgentech, Inc. Liquid composition for external application and preparation for external application for treatment of skin ulcer
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
JP2009179571A (en) * 2008-01-29 2009-08-13 Cellgentech Inc Agent for reinforcing wound-treating effect of g-csf by external application
JP5582711B2 (en) * 2008-09-25 2014-09-03 株式会社エー・アイ・システムプロダクト Lotion
ITTO20120258A1 (en) * 2012-03-21 2013-09-22 Fond Istituto Italiano Di Tecnologia POLYMERIC COMPOSITE MATERIALS WITH ANTIMICROBIAL AND BIODEGRADABLE PROPERTIES AND THEIR USES.
EP2861215A4 (en) 2012-06-13 2015-04-22 Evofem Inc Compositions and methods for enhancing the efficacy of contraceptive microbicides
KR102407408B1 (en) 2013-12-19 2022-06-10 에보펨 인코포레이티드 Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound
FR3023166B1 (en) * 2014-07-07 2018-01-12 Laboratoires Rivadis Sas USE OF A PHARMACEUTICAL COMPOSITION COMPRISING A PECTIN AS AN ACTIVE INGREDIENT IN THE PREVENTION AND / OR TREATMENT OF SKIN DISEASES INVOLVING INFLAMMATORY CHARACTER
CN110225750A (en) 2016-10-04 2019-09-10 伊沃菲姆股份有限公司 The treatment and prevention method of bacterial vaginosis BV
CN108742718B (en) * 2018-03-23 2021-04-16 苏州德锐特成像技术有限公司 Self-adhesive microneedle patch capable of swelling rapidly and preparation method thereof
BR112022013784A2 (en) 2020-01-13 2022-10-11 Durect Corp DISTRIBUTION SYSTEMS FOR PROLONGED RELEASE DRUGS WITH REDUCED IMPURITIES AND RELATED METHODS

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745098A (en) * 1984-02-24 1988-05-17 The Regents Of The University Of California Compositions and method for improving wound healing
JPS62153206A (en) * 1985-12-26 1987-07-08 Kanebo Ltd Skin cosmetic
NL9220019A (en) * 1992-04-10 1994-04-05 Vnii Med Polimerov PHARMACEUTICAL COMPOSITION.
GB9208731D0 (en) * 1992-04-22 1992-06-10 Squibb & Sons Inc Hydrocolloid wound gel
JP3279676B2 (en) * 1992-09-18 2002-04-30 アルケア株式会社 Skin protection material composition
JP2637672B2 (en) * 1992-11-10 1997-08-06 日本ビー・エックス・アイ株式会社 Composition for wound dressing
JP3583166B2 (en) * 1994-06-27 2004-10-27 興和株式会社 Powder preparation for damaged skin repair
JPH0940563A (en) * 1995-07-28 1997-02-10 Nippon Kayaku Co Ltd Composition for treating bed sore and skin ulcer
JP2953649B2 (en) * 1995-12-21 1999-09-27 岩城製薬株式会社 Topical powder for skin ulcer
ATE234105T1 (en) * 1996-06-05 2003-03-15 Tomifarm S R L COMPLEX PREPARATIONS CHARACTERIZED BY A CONTENT OF BETAIN
JP3420456B2 (en) * 1997-02-27 2003-06-23 ユニメディカル株式会社 Transdermal drug-coated membrane
JP3054758B2 (en) * 1997-03-27 2000-06-19 小林製薬株式会社 Trauma composition
JP3472442B2 (en) * 1997-06-05 2003-12-02 東亜薬品株式会社 Formulation for repairing damaged skin
JPH1149672A (en) * 1997-08-07 1999-02-23 Sato Seiyaku Kk Plaster for wound treatment
AU1347799A (en) * 1997-11-24 1999-06-15 Sherwood Services Ag Hydrocolloid wound dressing and the method of making and using the same
JP3114016B2 (en) * 1998-05-15 2000-12-04 株式会社ホギメディカル Wound hemostatic material having cell adhesion promoting effect
CA2317722A1 (en) * 1998-11-18 2000-05-25 Medical Industries Corp. Agents for repairing damaged tissue sites
JP2001097848A (en) * 1999-09-30 2001-04-10 Kobayashi Pharmaceut Co Ltd Preparation composition for external use
JP2002226378A (en) * 2001-01-30 2002-08-14 Mikasa Seiyaku Co Ltd Reepithelization promoter
JP2002226373A (en) * 2001-01-31 2002-08-14 Mikasa Seiyaku Co Ltd Preparation for therapy of bedsore, cutaneous ulcer and wound
JP4841733B2 (en) * 2001-01-31 2011-12-21 三笠製薬株式会社 Wound treatment formulation

Also Published As

Publication number Publication date
JPWO2004011032A1 (en) 2005-11-24
JP4712380B2 (en) 2011-06-29
WO2004011032A1 (en) 2004-02-05

Similar Documents

Publication Publication Date Title
AU2002335152A1 (en) Robot-phone
AU2003258549A1 (en) Maldi-matrix
AU2003252694A1 (en) External preparation
AU2003232754A1 (en) Diaminothiazoles
AU2002367810A1 (en) Bis-transition-metal-chelate-probes
AU2003264443A1 (en) Preparation for external use
AU2002368348A1 (en) Electrosomatogram
AU2002318053A1 (en) Suplier
AU2002348964A1 (en) Snowbike
AU2002341221A1 (en) Honey-brandy
AU2002953259A0 (en) Structure
AU2002344387A1 (en) Multifunction-pillow
AU2002100160A4 (en) Oxidirator
AU2002100031A4 (en) earliPay
AU2002100468A4 (en) Flexi-edger
AU2002100482A4 (en) Tail-gate-ezy
AU2002100498A4 (en) Linline
AU2002100508A4 (en) Photocard
AU2002100510A4 (en) Bottlenecker
AU2002100541A4 (en) Backmate
AU2002100602A4 (en) Bonsystem
AU2002100655A4 (en) Armamulch
AU2002100739A4 (en) Neuramax
AU2002100747A4 (en) Powersell
AU2002100957A4 (en) Sluggit

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase